IT1255968B - Composizioni farmaceutiche contenenti acido ursodesossicolico - Google Patents

Composizioni farmaceutiche contenenti acido ursodesossicolico

Info

Publication number
IT1255968B
IT1255968B ITMI922721A ITMI922721A IT1255968B IT 1255968 B IT1255968 B IT 1255968B IT MI922721 A ITMI922721 A IT MI922721A IT MI922721 A ITMI922721 A IT MI922721A IT 1255968 B IT1255968 B IT 1255968B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
compositions containing
acid
ursodesoxicolic
active ingredient
Prior art date
Application number
ITMI922721A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI922721A priority Critical patent/IT1255968B/it
Publication of ITMI922721A0 publication Critical patent/ITMI922721A0/it
Priority to ES93118886T priority patent/ES2134237T3/es
Priority to DE69325236T priority patent/DE69325236T2/de
Priority to EP93118886A priority patent/EP0599282B1/en
Priority to AT93118886T priority patent/ATE180969T1/de
Publication of ITMI922721A1 publication Critical patent/ITMI922721A1/it
Application granted granted Critical
Publication of IT1255968B publication Critical patent/IT1255968B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invenzione è relativa a composizioni farmaceutiche contenenti l'acido ursodesossicolico come principio attivo in forma di microgranuli ottenuti mediante estrusione/sferonizzazione di una miscela di acido ursodesossicolico ed altri eccipienti di comune impiego: ciò permette un rilascio controllato del principio attivo.
ITMI922721A 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico IT1255968B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI922721A IT1255968B (it) 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico
ES93118886T ES2134237T3 (es) 1992-11-27 1993-11-24 Composiciones farmaceuticas que contienen acido ursodesoxicolico.
DE69325236T DE69325236T2 (de) 1992-11-27 1993-11-24 Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
EP93118886A EP0599282B1 (en) 1992-11-27 1993-11-24 Pharmaceutical compositions containing ursodeoxycholic acid
AT93118886T ATE180969T1 (de) 1992-11-27 1993-11-24 Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922721A IT1255968B (it) 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico

Publications (3)

Publication Number Publication Date
ITMI922721A0 ITMI922721A0 (it) 1992-11-27
ITMI922721A1 ITMI922721A1 (it) 1994-05-27
IT1255968B true IT1255968B (it) 1995-11-17

Family

ID=11364369

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922721A IT1255968B (it) 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico

Country Status (5)

Country Link
EP (1) EP0599282B1 (it)
AT (1) ATE180969T1 (it)
DE (1) DE69325236T2 (it)
ES (1) ES2134237T3 (it)
IT (1) IT1255968B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
KR101414810B1 (ko) 2004-08-30 2014-07-18 주식회사 유스팜인터내셔널 국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과
ATE506955T1 (de) 2004-10-15 2011-05-15 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
JP2008521800A (ja) * 2004-11-24 2008-06-26 セオ ホン ユー 水可溶化胆汁酸投薬処方の乾燥形態、その製造方法及び用途
JP2010524926A (ja) * 2007-04-19 2010-07-22 ディスパル・インターナショナル・ビー．ブイ． ウルソデオキシコール酸の高用量組成物
MX2009001925A (es) * 2009-02-20 2010-08-20 Senosiain S A De C V Lab Composicion farmaceutica oral para uso en enfermedades respiratorias.
ITTO20111064A1 (it) * 2011-11-18 2013-05-19 Abc Farmaceutici S P A Compresse a rilascio protratto, comprendenti acido ursodesossicolico
US20220304937A1 (en) * 2015-09-16 2022-09-29 Laboratoires C.T.R.S. Pediatric formulation
CN107095858B (zh) * 2017-06-27 2020-04-10 石家庄学院 一种熊去氧胆酸胶囊及其制备方法
CN107496928B (zh) * 2017-09-11 2020-07-14 石家庄学院 一种熊去氧胆酸干混悬剂及其制备方法
US20220362158A1 (en) * 2019-06-28 2022-11-17 Tilman Sa Composition comprising at least one triterpene and/or at least one triterpenoid and/or at least one of the glycosylated forms thereof
CN110478304B (zh) * 2019-08-20 2022-07-05 广州市金熊大健康科技有限公司 一种含有熊胆微胶囊的牙膏
CA3259229A1 (en) * 2022-07-25 2024-02-01 Shilpa Medicare Limited NOR-UDCA PHARMACEUTICAL COMPOSITIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245891B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
ES2134237T3 (es) 1999-10-01
ITMI922721A1 (it) 1994-05-27
EP0599282A1 (en) 1994-06-01
DE69325236D1 (de) 1999-07-15
EP0599282B1 (en) 1999-06-09
ITMI922721A0 (it) 1992-11-27
ATE180969T1 (de) 1999-06-15
DE69325236T2 (de) 2000-01-27

Similar Documents

Publication Publication Date Title
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
CA2116120A1 (en) Peptides having growth hormone releasing activity
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES2115638T3 (es) Composicion tiroactiva de liberacion controlada.
MX9307686A (es) Preparacion de liberacion sostenida.
NZ295303A (en) Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
UA37196C2 (uk) Лікарська форма для перорального введення для лікування запальних хвороб кишкового тракту
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
DE68902531D1 (de) Dispergierbare zubereitung.
DE3862337D1 (de) Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten.
KR970705553A (ko) 디히드로벤조푸란, 및 항염증 약물로서 유용한 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
DE69325236D1 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
ATE135909T1 (de) Verfahren zur behandlung von akne
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
TW325404B (en) Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
IT1252185B (it) Preparazioni farmaceutiche a liberazione programmata
DE69732109D1 (de) Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
IT1263913B (it) Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
GB1110397A (en) Ephedrine composition
DK15088D0 (da) Antibakterielt lyofiliseret praeparat

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128